Advertisement

Treatment of Generalized Dermatitis

  • Susan T. Nedorost
Chapter

Keywords

Atopic Dermatitis Topical Corticosteroid Mycophenolate Mofetil Allergic Contact Dermatitis Topical Steroid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Haeck IM, Hamdy NA, Timmer-de Mik L, Lentjes EG, Verhaar HJ, Knol MJ, de Bruin-Weller MS, Bruijnzeel-Koomen CA. Low bone mineral density in adult patients with moderate to severe atopic dermatitis. Br J Dermatol. 2009;161(6):1248–54.PubMedCrossRefGoogle Scholar
  2. 2.
    Furukawa F, Kaminaka C, Ikeda T, Kanazawa N, Yamamoto Y, Ohta C, Nishide T, Tsujioka K, Hattori M, Uede K, Hata M, Wakayama Study Group on Dermatological Use of Bisphosphonates. Preliminary study of etidronate for prevention of corticosteroid-induced osteoporosis caused by oral glucocorticoid therapy. Clin Exp Dermatol. 2011;36(2):165–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Bair B, Dodd J, Heidelberg K, Krach K. Cataracts in atopic dermatitis: a case presentation and review of the literature. Arch Dermatol. 2011;147(5):585–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Dabade TS, Davis DM, Wetter DA, Hand JL, McEvoy MT, Pittelkow MR, El-Azhary RA, Davis MD. Wet dressing therapy in conjunction with topical corticosteroids is effective for rapid control of severe pediatric atopic dermatitis: experience with 218 patients over 30 years at Mayo Clinic. J Am Acad Dermatol. 2012;67:100–106.Google Scholar
  5. 5.
    Abeck D, Brockow K, Mempel M, Fesq H, Ring J. Treatment of acute exacerbated atopic eczema with emollient-antiseptic preparations using the “wet wrap” (“wet pajama”) technique. Hautarzt. 1999;50(6):418–21. German.PubMedCrossRefGoogle Scholar
  6. 6.
    Hindley D, Galloway G, Murray J, Gardener L. A randomised study of “wet wraps” versus conventional treatment for atopic eczema. Arch Dis Child. 2006;91(2):164–8.PubMedCrossRefGoogle Scholar
  7. 7.
    van Velsen SG, Haeck IM, Bruijnzeel-Koomen CA. Percutaneous absorption of potent topical corticosteroids in patients with severe atopic dermatitis. J Am Acad Dermatol. 2010;63­(5):911–3.PubMedCrossRefGoogle Scholar
  8. 8.
    Aubert-Wastiaux H, Moret L, Le Rhun A, Fontenoy AM, Nguyen JM, Leux C, Misery L, Young P, Chastaing M, Danou N, Lombrail P, Boralevi F, Lacour JP, Mazereeuw-Hautier J, Stalder JF, Barbarot S. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol. 2011;165(4):808–14.PubMedCrossRefGoogle Scholar
  9. 9.
    Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R, Ward SJ. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129(8):1892–908.PubMedCrossRefGoogle Scholar
  10. 10.
    Krejci-Manwaring J, Tusa MG, Carroll C, Camacho F, Kaur M, Carr D, Fleischer Jr AB, Balkrishnan R, Feldman SR. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56(2):211–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Glazenburg EJ, Wolkerstorfer A, Gerretsen AL, Mulder PG, Oranje AP. Efficacy and safety of fluticasone propionate 0.005% ointment in the long-term maintenance treatment of children with atopic dermatitis: differences between boys and girls? Pediatr Allergy Immunol. 2009;20(1):59–66.PubMedCrossRefGoogle Scholar
  12. 12.
    Sagransky MJ, Yentzer BA, Williams LL, Clark AR, Taylor SL, Feldman SR. A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol. 2010;146(12):1428–30.PubMedCrossRefGoogle Scholar
  13. 13.
    Schwarz A, Maeda A, Wild MK, Kernebeck K, Gross N, Aragane Y, Beissert S, Vestweber D, Schwarz T. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J Immunol. 2004;172(2):1036–43.PubMedGoogle Scholar
  14. 14.
    Sidbury R, Sullivan AF, Thadhani RI, Camargo Jr CA. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol. 2008;159(1):245–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Hartmann B, Riedel R, Jörss K, Loddenkemper C, Steinmeyer A, Zügel U, Babina M, Radbruch A, Worm M. Vitamin D receptor activation improves allergen-triggered eczema in mice. J Invest Dermatol. 2012;132(2):330–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Schram ME, Roekevisch E, Leeflang MM, Bos JD, Schmitt J, Spuls PI. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol. 2011;128(2):353–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Goujon C, Bérard F, Dahel K, et al. Methotrexate for the treatment of adult atopic dermatitis. Eur J Dermatol. 2006;16(2):155–8.PubMedGoogle Scholar
  18. 18.
    Neuber K, Schwartz I, Itschert G, Dieck AT. Treatment of atopic eczema with oral mycophenolate mofetil. Br J Dermatol. 2000;143­(2):385–91.PubMedCrossRefGoogle Scholar
  19. 19.
    Setshedi M, Epstein D, Winter TA, Myer L, Watermeyer G, Hift R. Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study. J Gastroenterol Hepatol. 2012;27:385–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Glück T, Müller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis. 2008;46(9):1459–65. Review.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2012

Authors and Affiliations

  • Susan T. Nedorost
    • 1
  1. 1.University Hospitals Case Medical Center UHMG DermatologyOhioUSA

Personalised recommendations